About Us
Founded in June 2020 in Abuja, the capital of Nigeria, Josef Shroeder Healthcare Limited is strategically invested by SHOLA-BAKARE ABIODUN, a prominent investor in Nigeria's pharmaceutical industry. Josefshroeder Healthcare Limited in partnership with Burning Rock Biotech Limited offers diagnostic services aimed towards precision oncology therapy. Such diagnosis involves Whole Exome Sequencing (WES) for cancer gene detection for various types of cancer. Identify genetic disorders linked to various cancers. For random screening, early detection purposes, minimal residual detection (MRD).
- Established: June 2020.
- Investor: Shola-Bakare Abiodun.
- Mission and Coverage: Africa and beyond.
Our vision
Our Mission
Our mission is to make high-quality, accessible, and efficient medical products and cutting-edge diagnostic tools available across West Africa and beyond, contributing to the health and well-being of the African people
Our promise
- High-Quality: Globally compliant test kits and medical equipments.
- Fast & Accurate: Reliable diagnostics for timely decision-making.
- Expert Support: Dedicated customer care and technical assistance.
- Tailored Solutions: Products designed to meet local healthcare needs.
Market Outlook
Our goal is to become the leading provider of healthcare products in West Africa, expanding our reach to cover the entire African continent. We are committed to improving healthcare accessibility and outcomes for millions of people.
Strategic vision
Establish regional leadership in West Africa before scaling across the African continent.